TruthArchive.ai - Related Video Feed

The speaker will be actively campaigning and believes President Trump will announce other Democrats joining his campaign. The speaker and President Trump both want to make America healthy again. The speaker discussed pharmaceutical company shareholder value with President Trump, who said his legacy would be healthy children and that he was unconcerned about other implications.

President Trump is prioritizing America by implementing reciprocal tariffs, a concept with bipartisan support. Trump aims to reverse decades of being the "world's ATM," referencing his 1988 concerns about trade imbalances with Japan and other countries not paying their fair share. The US has become overly reliant on adversaries like China, even for essential items like pharmaceuticals. Between 2020 and 2022, US imports of China-based pharmaceuticals grew by 485%. China now owns the American generic drug supply. Trump is implementing discounted reciprocal tariffs, charging China half of what they charge the US. Critics predict economic disaster, but Trump supporters argue these tariffs are essential for long-term independence and are already incentivizing investment in American factories. Critics accuse Trump of promising to lower the high cost of living, but now, quote, crashing the economy. Countering claims that Trump will cut Social Security, supporters say he explicitly stated he would not. The speaker claims the media lies about Trump, while Americans support his actions.

The speaker claims the United States spends $1,126 per capita on drugs, while Britain spends about $240, approximately one-fifth of the U.S. figure, a trend seen across Europe. The speaker says drug companies claim America must pay for pharmaceutical innovation. President Trump is quoted as saying European partners need to increase their drug payments to cover their share of innovation, asserting the U.S. should no longer subsidize it. The speaker concludes that if Europeans raised drug prices by 20%, the resulting $10 trillion could be spent on innovation, improving global health.

The speaker states they decided to break the system, referring to drug companies, which they describe as the most powerful lobby in the world. They claim drug companies have tremendous power over the Senate, the House, governors, and everybody. The speaker notes that drug companies spend billions of dollars. Despite this, the speaker says they don't care and must do what's right.

The speaker stated that they think it's ridiculous to suggest President Trump is acting for his own benefit. They claim he left a life of luxury and a successful real estate empire for public service, not just once, but twice, and the American public reelected him because they trust he acts in the country's best interest. The speaker asserted that Trump has lost money being president. They don't recall similar questions being asked of the previous president, a career politician who was allegedly profiting off the office. The speaker maintains that President Trump does not do this, and the White House holds itself to the highest ethical standards.

Not few doctors. What you're talking about is there's a big difference, senator, between established science and the the scientific establishment, which has been co opted by the pharmacy Hold on. So you're telling me you're telling the American people that the American Medical Association representing hundreds of thousands of people have been co opted and that they should not trust their doctors Are they all corrupt as well? And I'm telling you, the American Heart Association has been co opted by the flu You were brought in for president. You got a billionaire behind it. You received $300,000 from people, not from the industry, people in it as I did, from individuals. You corrupt, president Trump got $3,000,000 Every republican got corporate PAC money for the pharmaceutical industry, democrats as well Everybody is corrupt, but you? Is that what we're looking at? I don't think so. And I think the issue I don't even know

Former President Trump claims that he was the only president to take on big pharma, but Joe Biden canceled his toughened pharmaceutical policies. Trump signed an executive order to ensure that the US government pays the same price for pharmaceuticals as other countries, saving American patients billions of dollars. However, Biden reversed this order, allowing other countries to negotiate lower prices while Americans pay high prices. Trump promises that if he is reelected, he will sign an executive order to end this unfair practice and make Big Pharma lower prices for American patients. He believes that rescinding his original order shows the power of Big Pharma, but he is determined to deliver savings for seniors and all American patients.

I am implementing a rebate that cuts out the middlemen in the drug industry, reducing costs and benefiting the people purchasing the drugs. Despite facing opposition from wealthy individuals, I believe this is our only opportunity to make a change. No other president would take the steps I am taking, such as implementing favored nations and buying from other countries at lower prices. These actions have made a lot of rich people unhappy, but I am determined to prioritize the well-being of the people over their profits.

Pharmaceutical companies generate over two-thirds of their profits in the United States, despite the U.S. accounting for only 4% of the world's population. The speaker expresses respect for pharmaceutical companies and their leadership. They believe these companies successfully convinced people for many years that the current system was fair, even though the reasons why were not widely understood.

Pharmaceutical companies generate over two-thirds of their profits in the United States, despite the U.S. accounting for only 4% of the world's population. The speaker expresses respect for pharmaceutical companies and their leadership. They believe these companies successfully convinced people for many years that the existing system was fair, even though the reasons why were not well understood. The speaker claims to have figured out the reasons behind this.

I am implementing a rebate that cuts out the middlemen in the drug industry, reducing costs and benefiting the people who purchase the drugs. This has made me a target for wealthy individuals who are not pleased with my actions. However, I believe that we have a unique opportunity to make a change that no other president would dare to do. By implementing a favored nations approach and buying drugs from other countries at lower prices, we can further reduce costs. Despite the opposition from these rich individuals, I am determined to continue with this initiative.

The speaker thanks the president and clarifies that while they receive credit for guiding the administration toward the Maha movement, the president addressed the issue in a speech in June, before the speaker joined the campaign. The speaker notes this speech demonstrated potential for common ground. The speaker thanks the president for his vision and courage, stating that despite being labeled as favoring billionaires, the president supports the middle class, working class, and the poor. The speaker claims to have never seen a president, Democrat or Republican, willing to stand up to industry and address difficult issues like this president. The speaker recounts witnessing the president tell industry representatives that they would do things differently, delivering news they did not want to hear.

I aim to eliminate middlemen and reduce costs in the pharmaceutical industry, allowing the money saved to benefit drug purchasers. Unlike drug companies, who produce tangible products, these middlemen do not contribute in the same way. My enemies, who are wealthy individuals, are displeased with my actions. However, I believe this is our only opportunity to make a change, as no other president would take such steps. This may be my last appearance for a while.

Politicians have long promised to eliminate the discrepancy between drug prices in the U.S. and Europe. This was a key issue for Bernie Sanders, but previous leaders haven't acted on it. Politicians make these promises knowing they likely won't have to fulfill them. The reason is that Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every congressman, senator, and Supreme Court member.

Robert F. Kennedy Jr. praises President Trump for addressing the discrepancy between US and European drug prices, a promise unfulfilled by previous Democratic leaders due to pharmaceutical industry influence. Kennedy claims there is at least one pharmaceutical lobbyist for every congressman, senator, and Supreme Court member, and the industry spends three times more on lobbying than any other. Kennedy states that Trump cannot be bought and is standing up to oligarchs, unlike other politicians. He notes that the US, with 4.2% of the world's population, accounts for 75% of pharmaceutical company revenues, spending $11.26 per capita on drugs compared to Britain's $240. Kennedy says Trump is asking European partners to increase their drug payments to fund innovation, suggesting a 20% increase would free up $10 trillion for innovation and improve global health.

We're paying too much for drugs compared to other countries, and existing laws make it hard to lower costs. The middlemen in the drug industry are profiting significantly without adding value. We're going to eliminate these middlemen to reduce drug prices to unprecedented levels. This topic dominated our discussions with executives and others involved.

The speaker states they decided to break the system, referring to drug companies, which they describe as the most powerful lobby in the world with tremendous power over the Senate, the House, governors, and everybody. The speaker notes that drug companies spend billions of dollars. The speaker claims they don't care and have to do what's right.

I don't accept contributions from big pharma executives or corporate PAC money. You and your allies are aware of this.

The speaker acknowledges the strong influence of donors, special interests, and lobbyists over politicians. They claim to have turned down significant amounts of money from these sources, stating that they are not accepting any money from anyone except the people of the country. Speaker 1 brings up the speaker's past relationship with Hillary Clinton, suggesting that it worked for her. The speaker responds by saying that as a businessman, it was their job to get along with people, including politicians. They emphasize that they did a good job in doing so.

Almost all panel members, including you, are accepting significant contributions from the pharmaceutical industry. I ran for president too and received substantial contributions, but they did not come from executives. Out of 200 million, I received 1.5 million. You still haven't answered my last question.

I'm committed to making America healthier than other countries. Will you guarantee the same healthcare coverage that other major countries provide? Corruption isn't just in federal agencies; it's in Congress too. Many members here, including you, accept millions from the pharmaceutical industry to protect their interests. I ran for president and received millions in contributions, but none came from pharmaceutical executives or PACs. My support comes from workers, not corporate interests. You were the largest recipient of pharmaceutical donations in 2020. No, I received support from workers across the country, not from corporations. You still haven't answered the last question.

Politicians have long promised to address the discrepancy between drug prices in the U.S. and Europe. This issue was central to Bernie Sanders' presidential campaigns. However, these promises were never fulfilled because Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every member of Congress, the Senate, and the Supreme Court.

The media and career politicians are afraid of Donald J. Trump because he stands up against corruption and cannot be bought. Unlike other politicians, he cannot be influenced by money. We need someone like him in the White House who will fight for our values and our country. Let's not take him for granted and stand up for him just like he stood up for us. Share this video with a friend who needs to know.

Pharmaceutical companies spend three times more on lobbying than the next largest lobbyist. While many discussed the issue, nobody acted due to its controversial nature. President Trump, described as a man of his word, is willing to stand up to the oligarchs, unlike most politicians who can be bought. Despite allegedly receiving $100,000,000 from the pharmaceutical industry, Trump cannot be bought. The speaker praises President Trump for his courage and willingness to stand up for the American people.